Dynamiker is a high-tech enterprise integrated with R&D, production and sales. It is committed to developing a series of early, rapid and innovative in vitro diagnostic test kits for pathogenic microorganisms, which are highly demanded in different clinical fields. With its new products including Fungus (1-3)-β-D-Glucan Assay, Aspergillus Galactomannan Assay, Candida Mannan Assay, Cryptococcus neoformans Antigen Assay, Human Procalcitonin Assay, Dynamiker fills in the gap of early and rapid diagnosis for invasive fungal diseases in China, and thereby becoming a forefront leader in that field. Our company philosophy includes: - Integrity - Practicability - Openness - Innovation So far, the company is building innovative platforms for IVD products, developing an integrated sales network by continuously enhancing the quality of after-sales service and establishing a close cooperative relationship with more than twenty companies in Europe and the United States. We are committed to taking the lead in pathogenic microorganism diagnosis field and in vitro diagnostic industry in the coming 5 to 8 years.
Looking for a particular Dynamiker employee's phone or email?
The Dynamiker annual revenue was $8.3 million in 2026.
Amy Su is the CEO of Dynamiker.
19 people are employed at Dynamiker.
Dynamiker is based in Tianjin, Tianjian.
The NAICS codes for Dynamiker are [5417, 541, 54, 54171, 541711].
The SIC codes for Dynamiker are [283, 80, 28].